Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Delaware for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Delaware only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Delaware (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Robert Moyer (NPI 1861477077)

Field	Value
Entity Type	Individual
Organization	Robert Moyer
Address	1100 Forrest Ave
City	Dover
State	DE
ZIP	19904
Taxonomy	Rheumatology Physician
NPI Enumerated	December 9, 2005

Payer Source	Total Paid
Medicare	$1.3M
Medicaid	$0

Key Findings

This provider is effectively single‑payer at scale: Total Medicare revenue is $1.3M and there is no Medicaid billing on file, indicating the practice’s Medicare activity drives the entirety of the public-payer footprint shown. Analysts should treat Medicaid network exposure as absent based on the available claims record.

Revenue is highly concentrated in a small set of infusion/drug codes: the top three Medicare codes account for 73.8% of the provider’s Medicare revenue, with J0129 reported as $417.4K (31.5%), J0717 reported as $289.6K (21.9%), and J0897 reported as $271.1K (20.5%). This concentration signals that biologic drug administration is the primary revenue engine rather than routine office visits.

The code mix points to an infusion- and injectables‑centric rheumatology practice: J0129 (abatacept), J0717 (certolizumab pegol), J1602 (golimumab) and J1745 (infliximab) are prominent on the list, and multiple infusion/chemotherapy administration codes (96413, 96401, 96365, 96415) appear as well. Together these entries suggest on-site administration of biologic DMARDs and other parenteral therapies is a core service line rather than a purely consultative outpatient clinic.

On competitive standing, J0897 (denosumab) appears as an outlier versus national peers: it generated $271.1K (20.5%) of this provider’s Medicare revenue and is described as "notably above typical national volume" (95th percentile). That ranking implies this provider is a nationally high-volume reporter for denosumab administration relative to peers.

By contrast, the two largest biologic drug codes J0129 and J0717 are ranked at the 71th percentile and characterized as "typical, unremarkable volume," with $417.4K (31.5%) and $289.6K (21.9%) respectively. These placements indicate meaningful but not dominant national market share for those specific agents—substantial revenue contribution without being an outlier.

Evaluation/management codes contribute only a small share of revenue (for example 99213 at $8.9K (0.7%) and 99214 at $4.3K (0.3%)), reinforcing that the practice model is treatment- and infusion-driven rather than visit-volume driven. Low E/M revenue share suggests billing and operational capacity are optimized around drug administration sessions.

Several administration and infusion-addition codes sit at or above typical percentiles (96401 at the 89th percentile, 96372 and 99442 at the 93th percentile), which supports the inference of substantial infusion throughput in practice workflows. These higher percentile placements for administration codes corroborate the provider’s operational emphasis on in-office injections/infusions.

The provider has a long-established billing history, with NPI enumerated on 2005-12-09 (~21 years ago), which suggests a stable practice presence and an experienced operational setup for handling high-volume biologic administration. Given the concentration of revenue in infused biologics (top three = 73.8%), any payer reimbursement changes or shifts in biologic utilization could materially affect revenue, and payer negotiation or alternate-site infusion strategies would be relevant areas for analysts to monitor.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

15 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0129	Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)	12,280	$30	$417.4K
J0717	Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)	72,400	$1	$289.6K
J0897	Injection, denosumab, 1 mg	15,060	$20	$271.1K
J1602	Injection, golimumab, 1 mg, for intravenous use	16,000	$10	$176K
J1745	Injection, infliximab, excludes biosimilar, 10 mg	3,610	$30	$93.9K
96413	Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These…	220	$100	$21.5K
96401	The provider administers nonhormonal, antineoplastic chemotherapy drugs subcutaneously or intramuscularly to the patient.	380	$50	$19.9K
99213	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the…	140	$60	$8.9K
96365	The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease.	180	$50	$8.2K
99442	N/A	120	$70	$8K

Showing 1–10 of 15

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 15 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Delaware Distribution

Robert Moyer — 0 of 15 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Delaware

Full comparison — all codes billed, vs. state median

15 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0129	4	10	11,030	$30	$432.5K
J0717	7	10	98,800	$1	$376.8K
J1602	5	10	21,050	$10	$238.8K
J1745	5	10	3,610	$30	$134.3K
J0897	8	60	3,360	$20	$132.9K
96413	14	30	280	$100	$36.6K
99214	1,417	1,830	150	$80	$25.5K
96401	10	30	110	$60	$18.4K
99213	790	1,810	120	$60	$13.6K
96365	5	40	80	$50	$5K

Showing 1–10 of 15

Related Providers

Other providers that share a Tax Identification Number (TIN) with Robert Moyer, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Jinsong Zhang	DE	Rheumatology Physician	$3.5M	$0
Yvan Maque Acosta	DE	Rheumatology Physician	$1.3M	$0
Infusion Solutions Of Delaware	DE	Specialist	$0	$410K
Surjeet Dheer	DE	Rheumatology Physician	$382.7K	$0
Taras Yurchenko	DE	Medical Physician Assistant	$317.3K	$0

Nearby Providers

Other providers in the same ZIP code as Robert Moyer, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Bayada Home Health Care, Inc.	DE	Home Health Agency	$0	$37.9M
At Home Infucare, LLC	DE	Home Health Agency	$0	$28.5M
Amazing Home Care Agency	DE	Home Health Agency	$0	$18.7M
Dedicated To Women Ob-gyn, P.A.	DE	Obstetrics & Gynecology Physician	$0	$11.1M
Help At Home Of Delaware, LLC	DE	In Home Supportive Care Agency	$0	$10.7M
A Center For Mental Wellness, Inc.	DE	Mental Health Counselor	$0	$9.9M
State Of Delaware	DE	Case Management Agency	$0	$9.2M
West Dover Dental, LLC	DE	Dentist	$0	$9M
Americare Home Solutions	DE	In Home Supportive Care Agency	$0	$8.4M
Vicdania Health Services LLC	DE	Home Health Agency	$0	$7.4M

Robert Moyer — Billing Profile & Reimbursement Data

Sign up for Robert Moyer — Billing Profile & Reimbursement Data policy alerts

Robert Moyer — Billing Profile & Reimbursement Data

Sign up for Robert Moyer — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References